Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer
Clinical trial NCT02570711 · TERMINATED
Trial details
- NCT number
- NCT02570711
- Sponsor
- Acerta Pharma BV
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-13
- Primary completion
- 2016-04-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.